Article

Mediastinal lymph node dissection for non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery (Impact Factor: 4.17). 09/2005; 130(2):241-2. DOI: 10.1016/j.jtcvs.2005.03.037
Source: PubMed

ABSTRACT

The role of systematic mediastinal lymph node dissection in the staging and treatment of non-small cell lung cancer (NSCLC) is the subject of ongoing debate. Surgical practice varies from simple visual inspection of the unopened mediastinum to radical, systematic lymphadenectomy of all accessible lymph node levels. As the evaluation of mediastinal lymph nodes is a precondition for accurate intraoperative staging of NSCLC we advocate for complete interlobar, hilar and mediastinal lymphadenectomy as compartment dissections in patients with NSCLC. The therapeutic effect of extensive mediastinal lymphadenectomy, however, remains controversial. In this review we discuss the role of mediastinal lymph node dissection in the management of NSCLC.Copyright © 2010 S. Karger AG, Basel

  • Source
    • "file/ESTS_guidelines_on_preop_nodal_staging_NSCLC.pdf). There are several factors affecting the routine of individual surgeons practising lung cancer surgery, but it is clear that lymph node mapping is not as much integrated into the daily routine as it should be [4]. Problems with thoracic surgical training and individual attitudes are beyond our field. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In order to provide a precise lymph node mapping during lung cancer surgery a sterilizable plastic tray moulded in the shape of the mediastinum and lungs is presented by the author. The device makes lymph node mapping simpler, safer, quicker and methodically more structured. A positive impact is expected as a result of usage of the device from making pathologist’s work easier and facilitating the flux of information on the surgeon–pathologist–oncologist–pneumonologist chain to be more disinformation-free.
    Preview · Article · Mar 2007 · European Journal of Cardio-Thoracic Surgery
  • [Show abstract] [Hide abstract]
    ABSTRACT: Stage I and II non-small cell lung cancer (NSCLC) should be resected, but there is mounting evidence for the use of preoperative induction and postoperative adjuvant therapy in stages IB and II, as being able to prolong life. Some patients in stage IIIA should undergo induction therapy, and then have re-staging of the mediastinum by CT/PET or redo mediastinoscopy before considering resection. Stages IIIB and IV are non-surgical, except very selected cases. Reflections are made regarding the control of cigarette smoking, the difficult access of patients from developing countries to the recent costly medical, pharmacological and technical advances; reflections are also made related to some ethical issues regarding medical and surgical treatment of NSCLC.
    No preview · Article · Apr 2006 · Revista del Instituto Nacional de Enfermedades Respiratorias
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Stage I and II non–small cell lung cancer (NSCLC) should be resected, but there is mounting evidence for the use of preoperative induction and postoperative adjuvant therapy in stages IB and II, as being able to prolong life. Some patients in stage IIIA should undergo induction therapy, and then have re–staging of the mediastinum by CT/PET or redo mediastinoscopy before considering resection. Stages IIIB and IV are non–surgical, except very selected cases. Reflections are made regarding the control of cigarette smoking, the difficult access of patients from developing countries to the recent costly medical, pharmacological and technical advances; reflections are also made related to some ethical issues regarding medical and surgical treatment of NSCLC.
    Preview · Article · Jun 2006 · Revista del Instituto Nacional de Enfermedades Respiratorias
Show more